Pharma Export
- All
- News
- Videos
-
Any Tariff On Pharma Will Hit India, As 40% Exports Go To US: Report
Imposing tariffs on the pharmaceutical Industry will significantly impact the earnings of Indian pharma companies, as nearly 40 per cent of India's total pharma exports are directed to the US market, according to a report by SBI Research.
-
Trump Raises Tariffs To 50%: What It Means For India
US President Donald Trump today announced an additional 25 per cent tariff on goods coming from India as penalty for what he called New Delhi's continued buying of Russian oil.
-
Trump Says Tariffs On Pharma, Chips Coming By "Next Week Or So"
US President Donald Trump signaled Tuesday that fresh tariffs on imported pharmaceuticals and semiconductors could be unveiled as soon as the coming week, as he presses on in efforts to reshape global trade.
-
Tech, Pharma Among 6 Sectors Likely To Be Hit By Trump's 25% Tariffs On India
United States President Donald Trump announced 25 percent tariffs on imports from India, a measure which will likely impact some key sectors in India.
-
Amid Concern, Centre Plans Testing Drugs At Government Labs Before Export
Amid quality issues being raised globally for the cough syrups exported by Indian firms, the Centre is actively considering a proposal of testing drugs at government laboratories before they are dispatched to other countries.
-
Maiden Pharma Founder, Another Official Jailed In Decade-Old Case: Report
Two pharmaceutical company executives have been sentenced to two-and-half years in jail for exporting substandard drugs to Vietnam a decade ago, months after the WHO linked their cough syrups to the deaths of children in Gambia, reported Reuters.
-
Cough Syrup Deaths In Gambia Hits A Key Growth Area For India
Indian health authorities said on Wednesday they had halted all production of New Delhi-based Maiden Pharmaceuticals after a WHO report that its cough and cold syrups exported to Gambia may be linked to the deaths of dozens of children there.
-
Government Eases Export Curbs On 24 Pharma Ingredients, Medicines
The government on Monday relaxed export curbs on 24 pharma ingredients and medicines, including vitamin B1 and B12, according to an official notification.
-
India's Curb On Pharma Export Raises Concern On Coronavirus Drugs Shortage
US health regulators are watching for potential drug shortages after India restricted the export of some raw pharmaceutical ingredients, a move that could disrupt the industry's globe-spanning supply chain.
-
Government Puts Export Curbs On Pharma Ingredients Including Paracetamol Amid Virus Scare
The government on Tuesday put export restrictions on 26 pharma ingredients and medicines, including paracetamol, vitamin B1 and B12, amid the coronavirus outbreak in China, according to a government notification on Tuesday.
-
China To Provide "Greater Access" To Indian Anti-Cancer Drugs After Movie
China on Monday said it has initiated specific measures for the import of Indian pharmaceuticals, specially anti-cancer medicines, to provide them "greater access" to the Chinese market, days after a Chinese movie on a leukaemia patient highlighted the need for paving the way for import of cheap Indian medicines.
-
China's Plan To Import Indian Medicines Receives Cold Response From Pharma Firms
China's much-publicised announcement to slash tariffs on 28 medicines, including cancer drugs from India, has failed to create any buzz among the Indian pharmaceutical firms as exports to China are possible only after lengthy field trials and approvals, which could take years, an official at an Indian firm has said.
-
Pharma Firms Can Now Export Medicines, Devices Without 'No Objection Certificate'
To ensure ease of doing business, the Central Drugs Standard Control Organization (CDSCO) has waived the provision of procuring "no-objection" certificate (NOC) by pharmaceutical companies for exporting drugs, medical devices and cosmetics across ports in the country.
-
Here's Why Pharma Exports Dipped in FY17
In 2016-17, the exports decreased by 0.43% in value terms and 6.95% in volume terms, Minister of State for Commerce and Industry C R Chaudhary said
-
After H-1B, Strong Rupee The New Worry For Indian Tech Companies
For information technology and drug companies already contending with an American clampdown on working visas and a wave of unfavorable inspections by the U.S. Food and Drug Administration, rupee strength is another headache.
-
Any Tariff On Pharma Will Hit India, As 40% Exports Go To US: Report
Imposing tariffs on the pharmaceutical Industry will significantly impact the earnings of Indian pharma companies, as nearly 40 per cent of India's total pharma exports are directed to the US market, according to a report by SBI Research.
-
Trump Raises Tariffs To 50%: What It Means For India
US President Donald Trump today announced an additional 25 per cent tariff on goods coming from India as penalty for what he called New Delhi's continued buying of Russian oil.
-
Trump Says Tariffs On Pharma, Chips Coming By "Next Week Or So"
US President Donald Trump signaled Tuesday that fresh tariffs on imported pharmaceuticals and semiconductors could be unveiled as soon as the coming week, as he presses on in efforts to reshape global trade.
-
Tech, Pharma Among 6 Sectors Likely To Be Hit By Trump's 25% Tariffs On India
United States President Donald Trump announced 25 percent tariffs on imports from India, a measure which will likely impact some key sectors in India.
-
Amid Concern, Centre Plans Testing Drugs At Government Labs Before Export
Amid quality issues being raised globally for the cough syrups exported by Indian firms, the Centre is actively considering a proposal of testing drugs at government laboratories before they are dispatched to other countries.
-
Maiden Pharma Founder, Another Official Jailed In Decade-Old Case: Report
Two pharmaceutical company executives have been sentenced to two-and-half years in jail for exporting substandard drugs to Vietnam a decade ago, months after the WHO linked their cough syrups to the deaths of children in Gambia, reported Reuters.
-
Cough Syrup Deaths In Gambia Hits A Key Growth Area For India
Indian health authorities said on Wednesday they had halted all production of New Delhi-based Maiden Pharmaceuticals after a WHO report that its cough and cold syrups exported to Gambia may be linked to the deaths of dozens of children there.
-
Government Eases Export Curbs On 24 Pharma Ingredients, Medicines
The government on Monday relaxed export curbs on 24 pharma ingredients and medicines, including vitamin B1 and B12, according to an official notification.
-
India's Curb On Pharma Export Raises Concern On Coronavirus Drugs Shortage
US health regulators are watching for potential drug shortages after India restricted the export of some raw pharmaceutical ingredients, a move that could disrupt the industry's globe-spanning supply chain.
-
Government Puts Export Curbs On Pharma Ingredients Including Paracetamol Amid Virus Scare
The government on Tuesday put export restrictions on 26 pharma ingredients and medicines, including paracetamol, vitamin B1 and B12, amid the coronavirus outbreak in China, according to a government notification on Tuesday.
-
China To Provide "Greater Access" To Indian Anti-Cancer Drugs After Movie
China on Monday said it has initiated specific measures for the import of Indian pharmaceuticals, specially anti-cancer medicines, to provide them "greater access" to the Chinese market, days after a Chinese movie on a leukaemia patient highlighted the need for paving the way for import of cheap Indian medicines.
-
China's Plan To Import Indian Medicines Receives Cold Response From Pharma Firms
China's much-publicised announcement to slash tariffs on 28 medicines, including cancer drugs from India, has failed to create any buzz among the Indian pharmaceutical firms as exports to China are possible only after lengthy field trials and approvals, which could take years, an official at an Indian firm has said.
-
Pharma Firms Can Now Export Medicines, Devices Without 'No Objection Certificate'
To ensure ease of doing business, the Central Drugs Standard Control Organization (CDSCO) has waived the provision of procuring "no-objection" certificate (NOC) by pharmaceutical companies for exporting drugs, medical devices and cosmetics across ports in the country.
-
Here's Why Pharma Exports Dipped in FY17
In 2016-17, the exports decreased by 0.43% in value terms and 6.95% in volume terms, Minister of State for Commerce and Industry C R Chaudhary said
-
After H-1B, Strong Rupee The New Worry For Indian Tech Companies
For information technology and drug companies already contending with an American clampdown on working visas and a wave of unfavorable inspections by the U.S. Food and Drug Administration, rupee strength is another headache.
